SMTL ID : 9cd5.2 (1 other biounit)

FGFR1 Kinase Domain Soak with Inhibitor TYRA-300

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.94 Å

Oligo State

monomer

Ligands

1 x EDO: 1,2-ETHANEDIOL

EDO.1: 6 residues within 4Å: Chain A: E.74, M.78, I.88, D.184, F.185, G.186 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:E.74, A:D.184, A:D.184, A:F.185, A:G.186

1 x 01: (3P)-5-[(1R)-1-(3,5-dichloropyridin-4-yl)ethoxy]-3-{6-[6-(methanesulfonyl)-2,6-diazaspiro[3.3]heptan-2-yl]pyridin-3-yl}-1H-indazole

01.2: 14 residues within 4Å: Chain A: L.27, G.28, V.35, A.55, V.104, E.105, Y.106, A.107, S.108, G.110, N.111, R.170, L.173, D.184 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.27, A:L.27, A:V.35, A:V.104, A:Y.106, A:L.173 Hydrogen bonds: A:A.107, A:N.111 Halogen bonds: A:L.27, A:D.184

4 x SO4: SULFATE ION

SO4.3: 6 residues within 4Å: Chain A: R.113, R.170, T.200, N.202, R.204, W.209 8 PLIP interactions: 8 interactions with chain A Hydrogen bonds: A:N.202, A:N.202 Water bridges: A:R.170, A:T.201, A:N.202 Salt bridges: A:R.113, A:R.170, A:R.204 SO4.4: 7 residues within 4Å: Chain A: W.227, Y.244, L.256, H.260, R.261, M.262, W.280 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:Y.244, A:M.262, A:W.280 SO4.5: 7 residues within 4Å: Chain A: S.140, V.144, F.237, N.267, C.268, T.269, L.272 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:S.140, A:N.267, A:T.269 SO4.6: 1 residues within 4Å: Chain A: R.277 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:R.277

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hudkins, R.L. et al., Discovery of TYRA-300: First Oral Selective FGFR3 Inhibitor for the Treatment of Urothelial Cancers and Achondroplasia. J.Med.Chem. (2024)

Release Date

2024-09-25

Peptides

Fibroblast growth factor receptor 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Fibroblast growth factor receptor 1

Related Entries With Identical Sequence